A military school in Poland’s western town of Legnica had launched the country’s first drone course, teaching teenagers how ...

First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and PD data anticipated in Q1 2026 Advances ongoing ...

It is game time for SA’s Class of 2025 as matric exams get under way, starting with CAT and foreign languages before all ...

Just months left for the JEE Main 2025, the candidates can follow these preparation tips that will help them to boost their ...

A degree in computer science used to promise a cozy career in tech. Now, students’ ambitions are shaped by AI, in fields that ...

With a study, Mercedes shows how things will proceed in the luxury class. More exciting than the spectacular design is the ...

EMA committee recommends approval of Insmed’s Brinsupri to treat non-cystic fibrosis bronchiectasis: Bridgewater, New Jersey Monday, October 20, 2025, 15:00 Hrs [IST] Insmed Inc ...

Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, ...

Best-selling tablets from top brands up to 60% off! Enjoy 12 months No Cost EMI and exciting deals this Amazon Great Indian ...

The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) of small molecule ...

The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) ...

Preliminary data from first three patients in Phase 2b imaging clinical trial of RAD 101 show uptake in brain metastases from solid tumors, confirming proof-of-concept with Phase 2 topline results ...